Avanir Pharmaceuticals To Present at Three Conferences In May
ALISO VIEJO, Calif., May 1, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at three conferences in May.
- Deutsche Bank 37th Annual Health Care Conference
- Location: Intercontinental Hotel, Boston, MA
- Presentation date: Tuesday May 8, 2012
- Presentation time: 2:50 p.m. ET
- 11th Annual JMP Securities Research Conference
- Location: Ritz-Carlton, San Francisco, CA
- Presentation date: Monday May 14, 2012
- Presentation time: 3:30 p.m. PT
- Bank of America Merrill Lynch 2012 Health Care Conference
- Location: Encore at the Wynn, Las Vegas, NV
- Presentation date: Thursday May 17, 2012
- Presentation time: 10:00 a.m. PT
A live webcast and 30-day archive of these presentations will be available at http://ir.avanir.com.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.
AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.
©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.
Avanir Investor & Media Contact
Ian Clements, PhD
+1 (949) 389-6700
SOURCE Avanir Pharmaceuticals, Inc.
More by this Source
Avanir Pharmaceuticals to Participate in Two Conferences in March
Feb 28, 2014, 09:00 ET
Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Feb 07, 2014, 16:00 ET
Avanir Pharmaceuticals Reports Fiscal 2014 First Quarter Financial And Business Results
Feb 05, 2014, 16:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.